新诊断高级别胶质瘤患者早期与晚期静脉血栓栓塞的比较
该研究纳入894例新诊断胶质母细胞瘤及3-4级IDH突变胶质瘤患者,采用竞争风险分析估计VTE累积发生率,发现术后6个月内VTE风险快速上升,早期与晚期VTE危险因素不同,且GliomaPredictVTE工具显著低估VTE发生率。
要点
- 术后6个月内VTE风险最高,尤其老年、肢体无力及行走依赖者。
- 早期VTE(术后6个月内)与老年、肢体无力、行走依赖及单纯放疗相关。
- GliomaPredictVTE工具显著低估该人群VTE发生率。
核心结论
- 早期与晚期VTE具有不同的危险因素特征,支持在高危患者中开展一级预防的前瞻性研究,尤其是术后前6个月。
- GliomaPredictVTE工具在该人群中显著低估VTE发生率。
研究设计与样本
- 研究纳入2010-2023年894例新诊断胶质母细胞瘤和3-4级IDH突变胶质瘤患者。
- 采用竞争风险分析估计VTE累积发生率,分段线性回归模型确定早期与晚期VTE的变更点,竞争风险回归模型识别显著危险因素。
- 将GliomaPredictVTE预测的6个月和12个月VTE风险与观察到的累积发生率进行比较。
主要发现
- IDH野生型胶质母细胞瘤估计6个月和12个月VTE累积发生率分别为21.5%和26.4%,IDH突变胶质瘤分别为6.3%和8.3%。
- VTE累积发生率在术后前6个月快速上升,之后上升趋缓,变更点约在6个月。
- 多变量分析中,早期VTE(术后6个月内)显著与年龄较大、肢体无力、行走依赖和单纯放疗相关;晚期VTE(6个月至5年)与年龄较大和吸烟相关。
- GliomaPredictVTE平均预测6个月和12个月风险分别为11.0%和17.4%,而观察到的累积发生率分别为19.9%(p < 0.001)和23%(p = 0.008)。
临床怎么用
- 术后前6个月应重点关注VTE风险,尤其对老年、肢体无力及行走依赖患者考虑预防措施。
- GliomaPredictVTE工具在当前人群中的预测准确性不足,临床使用时需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Venous thromboembolism (VTE) occurs in 20-30% and 9.2% of patients with glioblastoma and grade 3 IDH mutant (IDHmut) gliomas respectively, with highest risk during the first months post-surgery. We sought to identify risk factors for early versus late VTE in high-grade gliomas and evaluated the recently proposed 'GliomaPredictVTE' tool. METHODS: We included 894 patients with newly-diagnosed glioblastoma and grade 3-4 IDHmut gliomas from 2010-2023. Competing-risk analysis estimated VTE cumulative incidence (CumInc), segmented linear regression model identified the change-point between early versus late VTE, and competing-risk regression model identified significant risk factors. GliomaPredictVTE-predicted 6- and 12-month VTE risks were compared to observed CumInc. RESULTS: The estimated 6- and 12-month VTE CumInc was 21.5% and 26.4%, respectively for IDHwt glioblastoma versus 6.3% and 8.3%, respectively for IDHmut gliomas. The VTE CumInc increased rapidly during the first 6 months post-surgery, followed by a more gradual rise thereafter, with a change-point around 6 months. On multivariable analyses, 'Early VTE' (within 6 months post-surgery) was significantly associated with older age, limb weakness, ambulation dependence, and radiotherapy alone; 'Late VTE' (6 months to 5 years) with older age and smoking. GliomaPredictVTE substantially underestimated VTE incidence in our population, with a mean predicted 6- and 12-month risks of 11.0% and 17.4%, versus observed CumInc of 19.9% (p < 0.001) and 23% (p = 0.008), respectively. CONCLUSIONS: Distinct risk profiles between early and late VTE support prospective studies of primary prophylaxis in high-risk patients, particularly in the first 6 months post-surgery. GliomaPredictVTE significantly underestimates VTE incidence in this population. Blood clots in the legs or lungs are a common and serious complication for patients with brain tumors called gliomas. Blood clots can shorten survival, delay cancer treatment and reduce quality of life. We examined when blood clots are most likely to occur and which patients face the greatest risk. We identified that the risk is highest within the first six months after tumor surgery, particularly patients who are older, with leg weakness and have difficulty walking. This information may allow doctors to use preventive measures to reduce clot formation and preserve survival and quality of life.
引用
- Jo J, Jin R, Kopp E, et al. Early versus late venous thromboembolism in patients with newly diagnosed high-grade gliomas. Neuro Oncol. 2026. PMID: 42921757. doi:10.1093/neuonc/noag268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。